Jiaoti Huang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Cell death & disease

Communications biology

NPJ precision oncology

Science signaling

Duke Medicine

New York University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke Medicine Jan 01 2016

United States

Professor and Chairman :: Pathology

Education History

New York University Sep 01 1987 - Dec 31 1990

United States

PHD :: Biochemistry

Publications

J Spencer Hauck, David Moon, Xue Jiang, Mu-En Wang, Yue Zhao, Lingfan Xu, Holly Quang, William Butler, Ming Chen, Everardo Macias, Xia Gao, Yiping He, Jiaoti Huang
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Communications biology 7 (1) (2024)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 15 (1) (2024)
Yen-Nien Liu, Wei-Yu Chen, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Phan Vu Thuy Dung, Zi-Qing Chen, Wei-Jiunn Lee, Michael Hsiao, Jiaoti Huang
MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT. Science signaling 17 (840) (2024)
J Spencer Hauck, David Moon, Xue Jiang, Mu-En Wang, Yue Zhao, Lingfan Xu, Holly Quang, William Butler, Ming Chen, Everardo Macias, Xia Gao, Yiping He, Jiaoti Huang
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Communications biology 7 (1) (2024)
J Spencer Hauck, David Moon, Xue Jiang, Mu-En Wang, Yue Zhao, Lingfan Xu, Holly Quang, William Butler, Ming Chen, Everardo Macias, Xia Gao, Yiping He, Jiaoti Huang
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Communications biology 7 (1) (2024)
Yen-Nien Liu, Wei-Yu Chen, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Phan Vu Thuy Dung, Zi-Qing Chen, Wei-Jiunn Lee, Michael Hsiao, Jiaoti Huang
MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT. Science signaling 17 (840) (2024)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 15 (1) (2024)
J Spencer Hauck, David Moon, Xue Jiang, Mu-En Wang, Yue Zhao, Lingfan Xu, Holly Quang, William Butler, Ming Chen, Everardo Macias, Xia Gao, Yiping He, Jiaoti Huang
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Communications biology 7 (1) (2024)
J Spencer Hauck, David Moon, Xue Jiang, Mu-En Wang, Yue Zhao, Lingfan Xu, Holly Quang, William Butler, Ming Chen, Everardo Macias, Xia Gao, Yiping He, Jiaoti Huang
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Communications biology 7 (1) (2024)
J Spencer Hauck, David Moon, Xue Jiang, Mu-En Wang, Yue Zhao, Lingfan Xu, Holly Quang, William Butler, Ming Chen, Everardo Macias, Xia Gao, Yiping He, Jiaoti Huang
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Communications biology 7 (1) (2024)
Michelle Shen, Shiqin Liu, Angus Toland, En-Chi Hsu, Alifiani B Hartono, Busola R Alabi, Merve Aslan, Holly M Nguyen, Conner J Sessions, Rosalie Nolley, Chanjuan Shi, Jiaoti Huang, James D Brooks, Eva Corey, Tanya Stoyanova
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype. British journal of cancer (2023)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (5) (2023)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (5) (2023)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (5) (2023)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (5) (2023)
William Butler, Colin T McDowell, Qing Yang, Yiping He, Yue Zhao, J Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J Armstrong, Daniel J George, Richard R Drake, Jiaoti Huang
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. NPJ precision oncology 7 (1) (2023)
Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (5) (2023)
William Butler, Colin T McDowell, Qing Yang, Yiping He, Yue Zhao, J Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J Armstrong, Daniel J George, Richard R Drake, Jiaoti Huang
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. NPJ precision oncology 7 (1) (2023)
William Butler, Colin T McDowell, Qing Yang, Yiping He, Yue Zhao, J Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J Armstrong, Daniel J George, Richard R Drake, Jiaoti Huang
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. NPJ precision oncology 7 (1) (2023)
Chun R Chao, Jeff M Slezak, Kimberly D Siegmund, Kimberly L Cannavale, Yu-Hsiang Shu, Gary W Chien, Xu-Feng Chen, Feng Shi, Nan Song, Stephen K Van den Eeden, Jiaoti Huang
Genome-wide methylation profiling of diagnostic tumor specimens identified DNA methylation markers associated with metastasis among men with untreated localized prostate cancer. Cancer medicine (2023)
Junhui Hu, Ping Tan, Moe Ishihara, Nicholas A Bayley, Shiruyeh Schokrpur, Jeremy G Reynoso, Yangjun Zhang, Raymond J Lim, Camelia Dumitras, Lu Yang, Steven M Dubinett, Parmjit S Jat, Jacques Van Snick, Jiaoti Huang, Arnold I Chin, Robert M Prins, Thomas G Graeber, Hua Xu, Lily Wu
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Jonathan Chou, Emily A Egusa, Sinan Wang, Michelle L Badura, Fei Lee, Anil Parsram Bidkar, Jun Zhu, Tanushree Shenoy, Kai Trepka, Troy M Robinson, Veronica Steri, Jiaoti Huang, Yuzhuo Z Wang, Eric J Small, Emily Chan, Bradley A Stohr, Alan Ashworth, Brant Delafontaine, Sylvie Rottey, Keegan S Cooke, Nooshin Hashemi Sadraei, Brian Yu, Mark Salvati, Julie M Bailis, Felix Y Feng, Robert Richard Flavell, Rahul R Aggarwal
Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer. Cancer research (2022)
Landon C Brown, Susan Halabi, Jason A Somarelli, Michael Humeniuk, Yuan Wu, Taofik Oyekunle, Lauren E Howard, Jiaoti Huang, Monika Anand, Catrin Davies, Prekshaben Patel, Janet Staats, Kent J Weinhold, Michael R Harrison, Tian Zhang, Daniel J George, Andrew J Armstrong
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer. Prostate cancer and prostatic diseases 25 (4) (2022)
Lingfan Xu, Bing Zhao, William Butler, Huan Xu, Nan Song, Xufeng Chen, J Spencer Hauck, Xia Gao, Hong Zhang, Jeff Groth, Qing Yang, Yue Zhao, David Moon, Daniel George, Yinglu Zhou, Yiping He, Jiaoti Huang
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer. Oncogene 41 (8) (2022)
Yu-Ching Wen, Wei-Yu Chen, Van Thi Ngoc Tram, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Wassim Abou-Kheir, Jiaoti Huang, Michael Hsiao, Yen-Nien Liu
Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency. Cell death & disease 13 (3) (2022)
Thomas C Westbrook, Xiangnan Guan, Eva Rodansky, Diana Flores, Chia Jen Liu, Aaron M Udager, Radhika A Patel, Michael C Haffner, Ya-Mei Hu, Duanchen Sun, Tomasz M Beer, Adam Foye, Rahul R Aggarwal, David A Quigley, Jack F Youngren, Charles J Ryan, Martin Gleave, Yuzhuo Z Wang, Jiaoti Huang, Ilsa Coleman, Colm Morrissey, Peter S Nelson, Christopher P Evans, Primo Lara, Robert E Reiter, Owen Witte, Matthew Rettig, Christopher K Wong, Alana S Weinstein, Vladislav Uzunangelov, Joshua M Stuart, George V Thomas, Felix Y Feng, Eric J Small, Joel Anthony Yates, Zheng Xia, Joshi J Alumkal
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. Nature communications 13 (1) (2022)
Bushu Dong, Alex M Jaeger, Philip F Hughes, David R Loiselle, J Spencer Hauck, Yao Fu, Timothy A Haystead, Jiaoti Huang, Dennis J Thiele
Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1. Science translational medicine 12 (574) (2021)
Lingfan Xu, Yu Yin, Yanjing Li, Xu-Feng Chen, Yan Chang, Hong Zhang, Juan Liu, James Beasley, Patricia McCaw, Haoyue Zhang, Sarah P Young, Jeff Groth, Qianben Wang, Jason W Locasale, Xia Gao, Dean G Tang, Xuesen Dong, Yiping He, Daniel George, Hailiang Hu, Jiaoti Huang
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 118 (13) (2021)
Yanjing Li, Yiping He, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C Gao, Qingfu Zhang, Daniel G Taylor, Donghui Cheng, Suzette Farber-Katz, Rachid Karam, Tyler Landrith, Bing Li, Sitao Wu, Vickie Hsuan, Qing Yang, Hailiang Hu, Xu-Feng Chen, Melissa Flowers, Shannon J McCall, John K Lee, Bryan A Smith, Jung Wook Park, Andrew S Goldstein, Qianben Wang, Matthew B Rettig, Andrew J Armstrong, Qing Cheng, Jiaoti Huang
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Science translational medicine 11 (521) (2020)
Jung Wook Park, John K Lee, Katherine M Sheu, Liang Wang, Nikolas G Balanis, Kim Nguyen, Bryan A Smith, Chen Cheng, Brandon L Tsai, Donghui Cheng, Jiaoti Huang, Siavash K Kurdistani, Thomas Glen Graeber, Owen N Witte
Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science (New York, N.Y.) 362 (6410) (2019)

Jiaoti Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jiaoti Huang